Browse All

Current Filters

CLEAR FILTER x

TITLE

Reducing Out-of-pocket Costs of Disease-modifying Therapies for Medicare Part D Beneficiaries with Multiple Sclerosis: A Call to Action for Neurologists

Medicare Part D Utilization, Spending, and Formulary Coverage of Brand-name Disease Modifying Therapies with Generics Available for Multiple Sclerosis